Carotid revascularization using endarterectomy or stenting systems (CaRESS) phase I clinical trial: 1-year results

被引:158
作者
White, RA [1 ]
Diethrich, E [1 ]
Fogarty, TJ [1 ]
Zarins, CK [1 ]
Hopkins, LN [1 ]
Roubin, GS [1 ]
Wholey, MH [1 ]
Nimsky, S [1 ]
McKinlay, S [1 ]
Siami, FS [1 ]
机构
[1] New England Res Inst, Watertown, MA 02472 USA
关键词
D O I
10.1016/j.jvs.2005.04.023
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Current clinical trials evaluating carotid stenting have focused on high-risk patients and may not reflect the broad population of patients with carotid stenosis who undergo treatment to prevent stroke. The Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I study is a multicenter, prospective, nonrandomized trial designed to address the question of whether carotid stenting (CAS) with cerebral protection is comparable to carotid endarterectomy (CEA) in patients with symptomatic and asymptomatic carotid stenosis. Methods: Patients with symptomatic (with > 50% stenosis) or asymptomatic (with > 75% stenosis) carotid stenosis were entered into the study in a 2:1 ratio of carotid stent and GuardWire Plus distal protection device. This unique trial model was developed through collaboration with the International Society of Endovascular Specialists, the Food and Drug Administration, the Centers for Medicare and Medicaid Services, the National Institutes of Health, and industry representatives. The primary end points included death and stroke at 30 days and a composite 1-year end point of death, stroke, or myocardial infarction (MI) from 0 to 30 days and death or stroke from 31 days to 1 year. The secondary end points included residual stenosis, restenosis, repeat angiography, and carotid revascularization at 30 days and 1 year and quality-of-life changes at I year. Results: A total of 397 patients (254 CEA and 143 CAS) were enrolled in the study: 32% were symptomatic and 68% were asymptomatic. There were no significant differences in patient characteristics, symptoms, or surgical risk profiles between groups at baseline. Kaplan-Meier analysis revealed no significant differences in combined death/stroke rates at 30 days (3.6% CEA vs 2.1% CAS) or at I year (13.6% CEA vs 10.0% CAS). Similarly, there was no significant difference in the combined end point of death, stroke, or MI at 30 days (4.4% CEA vs 2.1% CAS) or at I year (14.3% CEA vs 10.9% CAS). There were no significant differences between CEA and CAS in the secondary end points of residual stenosis (0% CEA vs 0.9% CAS), restenosis (3.6% CEA vs; 6.3% CAS), repeat angiography (2.1% CEA vs 3.6% CAS), carotid revascularization (1.0% CEA vs 1.8% CAS), or change in quality of life (-1.56 points CEA vs -4.22 points CAS). Conclusions. The CaRESS phase I study suggests that the 30-day and 1-year risk of death, stroke, or MI with CAS is equivalent to that with CEA in symptomatic and asymptomatic patients with carotid stenosis.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 19 条
  • [1] Development of the multidimensional index of life quality - A quality of life measure for cardiovascular disease
    Avis, NE
    Smith, KW
    Hambleton, RK
    Feldman, HA
    Selwyn, A
    Jacobs, A
    [J]. MEDICAL CARE, 1996, 34 (11) : 1102 - 1120
  • [2] AVIS NE, 1995, MULTIDIMENSIONAL IND
  • [3] GRAY WA, 2005, ARCHER EXECUTIVE COM
  • [4] Hobson R W 2nd, 2000, Semin Vasc Surg, V13, P139
  • [5] HOPKINS LN, 2005, CAROTID ARTERY REVAS
  • [6] DETECTION AND QUANTIFICATION OF CAROTID-ARTERY STENOSIS - EFFICACY OF VARIOUS DOPPLER VELOCITY PARAMETERS
    HUNINK, MGM
    POLAK, JF
    BARLAN, MM
    OLEARY, DH
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1993, 160 (03) : 619 - 625
  • [7] Redefined duplex ultrasonographic criteria for diagnosis of carotid artery stenosis
    Huston, J
    James, EM
    Brown, RD
    Lefsrud, RD
    Ilstrup, DM
    Robertson, EF
    Meyer, FB
    Hallett, JW
    [J]. MAYO CLINIC PROCEEDINGS, 2000, 75 (11) : 1133 - 1140
  • [8] Duplex ultrasound criteria for the identification of carotid stenosis should be laboratory specific
    Kuntz, KM
    Polak, JF
    Whittemore, AD
    Skillman, JJ
    Kent, KC
    [J]. STROKE, 1997, 28 (03) : 597 - 602
  • [9] Carotid revascularization using endarterectomy or stenting systems (CARESS): Phase I clinical trial - CARESS steering committee
    McKinlay, S
    [J]. JOURNAL OF ENDOVASCULAR THERAPY, 2003, 10 (06) : 1021 - 1030
  • [10] Preprocedural risk stratification: Identifying an appropriate population for carotid stenting
    Ouriel, K
    Hertzer, NR
    Beven, EG
    O'Hara, P
    Krajewski, LP
    Clair, DG
    Greenberg, RK
    Sarac, TP
    Olin, JW
    Yadav, JS
    [J]. JOURNAL OF VASCULAR SURGERY, 2001, 33 (04) : 728 - 732